Scientists demonstrate utility of bilateral tumour model for evaluating anti-cancer T-cell responses Read more
Ascletis announces signing of Ritonavir tablet purchase agreement with Phokam Pharmaceutical Read more
Merck allocates three million courses of Molnupiravir to be provided in first half of 2022 for use in LMICs Read more
Stempeutics gets DCGI nod for phase-III clinical trial on its product for treating COVID patients Read more